Accès à distance ? S'identifier sur le proxy UCLouvain
BTI-322 for induction therapy after renal transplantation: a randomized study
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 1997 |
Journal information | "Transplantation Proceedings" - Vol. 29, no. 1-2, p. 317-319 (1997) |
Peer reviewed | yes |
Publisher | Elsevier Inc. (Philadelphia) |
issn | 0041-1345 |
e-issn | 1873-2623 |
Publication status | Publié |
Affiliations |
UCL
- MD/CHIR - Département de chirurgie UCL - (SLuc) Service de chirurgie et transplantation abdominale UCL - (SLuc) Centre du cancer UCL - MD/MINT - Département de médecine interne UCL - (SLuc) Service de néphrologie |
MESH Subject | Antibodies, Monoclonal - therapeutic use ; Azathioprine - therapeutic use ; Cyclosporine - therapeutic use ; Graft Rejection - epidemiology - prevention & control - therapy ; Graft Survival ; Humans ; Immunosuppression ; Immunosuppressive Agents - therapeutic use ; Kidney Transplantation - immunology - mortality ; Prednisolone - therapeutic use ; Survival Rate ; Transplantation, Homologous |
Links |
Bibliographic reference | Squifflet, Jean-Paul ; Besse, T. ; Malaise, Jacques ; Mourad, Michel ; Delcorde, C. ; et. al. BTI-322 for induction therapy after renal transplantation: a randomized study. In: Transplantation Proceedings, Vol. 29, no. 1-2, p. 317-319 (1997) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/29590 |